TY - JOUR
T1 - Association of single nucleotide polymorphisms with dyslipidemia and risk of metabolic disorders in the State of Qatar
AU - Al-Sharshani, Dalal
AU - Velayutham, Dinesh
AU - Samara, Muthanna
AU - Gazal, Reham
AU - Al Haj Zen, Ayman
AU - Ismail, Mohamed A.
AU - Ahmed, Mahmoud
AU - Nasrallah, Gheyath
AU - Younes, Salma
AU - Rizk, Nasser
AU - Hammuda, Sara
AU - Qoronfleh, M. Walid
AU - Farrell, Thomas
AU - Zayed, Hatem
AU - Abdulrouf, Palli Valapila
AU - AlDweik, Manar
AU - Silang, John Paul Ben
AU - Rahhal, Alaa
AU - Al-Jurf, Rana
AU - Mahfouz, Ahmed
AU - Salam, Amar
AU - Al Rifai, Hilal
AU - Al-Dewik, Nader I.
N1 - Note: This work was supported by the Qatar Genome Project and
Qatar biobank. The publication of this article is funded by the Qatar National Library (QNL), Doha, Qatar.
PY - 2023/5/5
Y1 - 2023/5/5
N2 - Background: Dyslipidemia is recognized as one of the risk factors of cardiovascular diseases (CVDs), type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD).
Objective: The study aimed to investigate the association between selected single nucleotide polymorphisms (SNPs) with dyslipidemia and increased susceptibility risks of CVD, NAFLD, and/or T2DM in dyslipidemia patients in comparison with healthy control individuals from the Qatar genome project.
Methods: A community-based cross-sectional study was conducted among 2933 adults (859 dyslipidemia patients and 2074 healthy control individuals) from April to December 2021 to investigate the association between 331 selected SNPs with dyslipidemia and increased susceptibility risks of CVD, NAFLD and/or T2DM, and covariates.
Results: The genotypic frequencies of six SNPs were found to be significantly different in dyslipidemia patients subjects compared to the control group among males and females. In males, three SNPs were found to be significant, the rs11172113 in over-dominant model, the rs646776 in recessive and over-dominant models, and the rs1111875 in dominant model. On the other hand, two SNPs were found to be significant in females, including rs2954029 in recessive model, and rs1801251 in dominant and recessive models. The rs17514846 SNP was found for dominant and over-dominant models among males and only the dominant model for females. We found that the six SNPs linked to gender type had an influence in relation to disease susceptibility. When controlling for the four covariates (gender, obesity, hypertension, and diabetes), the difference between dyslipidemia and the control group remained significant for the six variants. Finally, males were three times more likely to have dyslipidemia in comparison with females, hypertension was two times more likely to be present in the dyslipidemia group, and diabetes was six times more likely to be in the dyslipidemia group.
Conclusion: The current investigation provides evidence of association for a common SNP to coronary heart disease and suggests a sex-dependent effect and encourage potential therapeutic applications.
Keywords: Qatar genome project (QGP); cardiovascular disease (CVD); coronary artery disease (CAD); diabetes; dyslipidemia; hypertension; metabolic; non-alcoholic fatty liver disease (NAFLD); single nucleotide polymorphism (SNP).
© 2023 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
AB - Background: Dyslipidemia is recognized as one of the risk factors of cardiovascular diseases (CVDs), type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD).
Objective: The study aimed to investigate the association between selected single nucleotide polymorphisms (SNPs) with dyslipidemia and increased susceptibility risks of CVD, NAFLD, and/or T2DM in dyslipidemia patients in comparison with healthy control individuals from the Qatar genome project.
Methods: A community-based cross-sectional study was conducted among 2933 adults (859 dyslipidemia patients and 2074 healthy control individuals) from April to December 2021 to investigate the association between 331 selected SNPs with dyslipidemia and increased susceptibility risks of CVD, NAFLD and/or T2DM, and covariates.
Results: The genotypic frequencies of six SNPs were found to be significantly different in dyslipidemia patients subjects compared to the control group among males and females. In males, three SNPs were found to be significant, the rs11172113 in over-dominant model, the rs646776 in recessive and over-dominant models, and the rs1111875 in dominant model. On the other hand, two SNPs were found to be significant in females, including rs2954029 in recessive model, and rs1801251 in dominant and recessive models. The rs17514846 SNP was found for dominant and over-dominant models among males and only the dominant model for females. We found that the six SNPs linked to gender type had an influence in relation to disease susceptibility. When controlling for the four covariates (gender, obesity, hypertension, and diabetes), the difference between dyslipidemia and the control group remained significant for the six variants. Finally, males were three times more likely to have dyslipidemia in comparison with females, hypertension was two times more likely to be present in the dyslipidemia group, and diabetes was six times more likely to be in the dyslipidemia group.
Conclusion: The current investigation provides evidence of association for a common SNP to coronary heart disease and suggests a sex-dependent effect and encourage potential therapeutic applications.
Keywords: Qatar genome project (QGP); cardiovascular disease (CVD); coronary artery disease (CAD); diabetes; dyslipidemia; hypertension; metabolic; non-alcoholic fatty liver disease (NAFLD); single nucleotide polymorphism (SNP).
© 2023 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
KW - Cardiovascular medicine
U2 - 10.1002/mgg3.2178
DO - 10.1002/mgg3.2178
M3 - Article
C2 - 37147786
SN - 2324-9269
JO - Molecular Genetics and Genomic Medicine
JF - Molecular Genetics and Genomic Medicine
M1 - e2178
ER -